• linkedin
  • Increase Font
  • Sharebar

    10 More Newly Approved Drugs

    The FDA is having a productive 2017.

     

    Alunbrig logo

    ALUNBRIG (brigatinib), Takeda

    Indications: a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

    Dosage: 90 mg orally once daily for the first 7 days; if tolerated, increase to 180 mg orally once daily.

    Contraindications: None.

    Read the prescribing information here

    Previous ButtonNext Button

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available
    Slideshows
    Small Doses: Sex, Drugs, and Other Pharmacy News
    Small Doses: Sex, Drugs, and Other ...

    Easy-to-swallow bits of news from around the world of pharmacy.

    Small Doses: The Weekly News You ...